Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000734327 | SCV000727838 | likely benign | not provided | 2021-01-13 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 32880476) |
Labcorp Genetics |
RCV000643766 | SCV000765453 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-09-06 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000734327 | SCV000862458 | uncertain significance | not provided | 2018-07-18 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798924 | SCV002043065 | uncertain significance | Cardiomyopathy | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377318 | SCV002667694 | uncertain significance | Cardiovascular phenotype | 2019-10-15 | criteria provided, single submitter | clinical testing | The p.R22007C variant (also known as c.66019C>T), located in coding exon 166 of the TTN gene, results from a C to T substitution at nucleotide position 66019. The arginine at codon 22007 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000734327 | SCV003819709 | uncertain significance | not provided | 2023-08-14 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000734327 | SCV002034626 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000734327 | SCV002037404 | uncertain significance | not provided | no assertion criteria provided | clinical testing |